Should you buy Braskem (BAK)?
Updated
Braskem sits outside the investable universe by market capitalization at $0.84 billion — below the $1 billion minimum threshold — and carries cash-burning operations with free cash flow negative at 10% of revenue, a 20% revenue decline, and a Piotroski financial health score of only 3 out of 9; despite a sharp 44% upward revision to analyst estimates over the last month, the fundamental setup does not support investment.
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Engine methodology range
Range computation requires sufficient peer-comparable data; available for tickers with peer_count ≥3.
What the engine is tracking
| Pillar | Expectation | Trend |
|---|---|---|
With a market capitalization of $0.84 billion, the company falls below the $1 billion minimum investable threshold, excluding it from most institutional mandates and reducing the pool of potential buyers that could sustain price support. Warnings | Market capitalization rises above $1.5 billion for 2 consecutive months before the size constraint is meaningfully resolved. | →Stable |
| CounterA sub-$1 billion market cap can also signal a deep-value recovery opportunity where re-entry into the investable universe triggers a significant institutional re-rating event for investors willing to tolerate the illiquidity. | ||
The company is burning cash at a rate equal to 10% of revenue, carries a Piotroski financial health score of only 3 out of 9, and has been assessed as having no competitive moat — a combination signaling acute fundamental distress rather than a temporary cyclical trough. Quality breakdown | Free cash flow turns positive and the Piotroski score improves above 5 out of 9 for 2 consecutive quarters before the quality picture can be reassessed. | →Stable |
| CounterAnalyst estimates have been revised upward by 44% in the last 30 days, which — if grounded in real cost reduction or commodity price recovery — could move the company toward cash generation faster than the current score implies. | ||
Revenue has contracted 20% year-over-year and the company missed earnings estimates in 2 of the last 3 reported quarters — including a 239% miss below expectations in the most recent quarter — making it difficult to underwrite a near-term earnings recovery with confidence. Earnings | Revenue growth turns positive year-over-year and EPS comes within 10% of consensus estimates for 2 consecutive quarters before the fundamental thesis can be revisited. | →Stable |
| CounterWith RSI at deeply oversold levels and on-balance volume rising, a technical re-rating is possible even before fundamentals recover, potentially producing a sharp short-covering bounce that precedes the fundamental turn. | ||
With a market capitalization of $0.84 billion, the company falls below the $1 billion minimum investable threshold, excluding it from most institutional mandates and reducing the pool of potential buyers that could sustain price support.
→Stable- Expectation
- Market capitalization rises above $1.5 billion for 2 consecutive months before the size constraint is meaningfully resolved.
CounterA sub-$1 billion market cap can also signal a deep-value recovery opportunity where re-entry into the investable universe triggers a significant institutional re-rating event for investors willing to tolerate the illiquidity.
The company is burning cash at a rate equal to 10% of revenue, carries a Piotroski financial health score of only 3 out of 9, and has been assessed as having no competitive moat — a combination signaling acute fundamental distress rather than a temporary cyclical trough.
→Stable- Expectation
- Free cash flow turns positive and the Piotroski score improves above 5 out of 9 for 2 consecutive quarters before the quality picture can be reassessed.
CounterAnalyst estimates have been revised upward by 44% in the last 30 days, which — if grounded in real cost reduction or commodity price recovery — could move the company toward cash generation faster than the current score implies.
Revenue has contracted 20% year-over-year and the company missed earnings estimates in 2 of the last 3 reported quarters — including a 239% miss below expectations in the most recent quarter — making it difficult to underwrite a near-term earnings recovery with confidence.
→Stable- Expectation
- Revenue growth turns positive year-over-year and EPS comes within 10% of consensus estimates for 2 consecutive quarters before the fundamental thesis can be revisited.
CounterWith RSI at deeply oversold levels and on-balance volume rising, a technical re-rating is possible even before fundamentals recover, potentially producing a sharp short-covering bounce that precedes the fundamental turn.
▸ Show 1 more pillar▾ Show fewer
A 44% upward revision to analyst estimates over the last 30 days introduces a speculative element — if the revision cycle has legs, it may attract momentum buyers even before underlying fundamentals improve meaningfully.
→Stable- Expectation
- Analyst estimates continue rising for at least 2 more consecutive months and the EPS revision trend produces a beat rather than a miss in the next reported quarter, validating the revision cycle.
CounterWith an average EPS surprise of negative 25% over the last four quarters and negative news sentiment, there is a meaningful probability that the revision cycle overshoots the underlying reality and is followed by another material miss, trapping speculative buyers who acted on the estimate momentum.
→ Full pillar scorecard with all 4 pillars + per-dimension breakdown
When this thesis breaks
Falsifiable conditions per pillar — any one trip warrants review independent of price action. Engine-derived; not personalized advice.
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1With a market capitalization of $0.84 billion, the company falls below the $1 billion minimum investable threshold, excluding it from most institutional mandates and reducing the pool of potential buyers that could sustain price support.
Trip ifMarket capitalization exceeds $1.5 billion for 2 consecutive months, clearing the minimum investable threshold with margin.
- P2The company is burning cash at a rate equal to 10% of revenue, carries a Piotroski financial health score of only 3 out of 9, and has been assessed as having no competitive moat — a combination signaling acute fundamental distress rather than a temporary cyclical trough.
Trip ifFree cash flow rises above $0 for 2 consecutive quarters, removing the cash-burn concern.
- P3Revenue has contracted 20% year-over-year and the company missed earnings estimates in 2 of the last 3 reported quarters — including a 239% miss below expectations in the most recent quarter — making it difficult to underwrite a near-term earnings recovery with confidence.
Trip ifRevenue growth exceeds 5% year-over-year for 2 consecutive quarters, reversing the current 20% contraction.
- P4A 44% upward revision to analyst estimates over the last 30 days introduces a speculative element — if the revision cycle has legs, it may attract momentum buyers even before underlying fundamentals improve meaningfully.
Trip ifEPS comes in within 5% above consensus estimates for 2 consecutive quarters, confirming the revision cycle has translated into actual earnings delivery.
How the engine reached this verdict
TrendMatrix's engine output for Braskem SA (BAK) is HOLD_IF_HOLDING with medium conviction, score 4.8/10 at $2.52. An L1 hard-floor gate blocked the positive-verdict path — Market cap $0.66B below $1B minimum. Not in investable universe. Co-failing gates ( MOMENTUM:2.1<4.5) reinforce the read; dimensional pillars cannot lift the engine output above the verdict floor while the L1 gate is active.
On the bear side: Market cap $0.66B below $1B minimum. Active engine warnings: Market cap $0.66B below $1B minimum, V9 Gate Failed: MOMENTUM:2.1<4.5.
The engine is not issuing fresh-money entry targets at the current verdict. The technical entry zone is around — with a technical stop near $2.43 for existing positions. Asymmetric R:R is 7.82, below the threshold (≥2.0) at which the engine would actively flag fresh capital. The engine's sizing output: 0.5% of portfolio at this asymmetry level (none-conviction tier).
HOLD flips toward BUY_WAIT if momentum at 2.1 vs threshold 4.5 clears AND a co-confirming gate triggers. HOLD flips toward SELL if any of the currently-passing gates drop below threshold OR three or more dimensions fall below 4 simultaneously.
For the full 10-dimension breakdown + V9 gate detail: Why TrendMatrix rates BAK — 10-dimension breakdown →
Bear case
- ▸Market cap $0.66B below $1B minimum